RxDoctor Payments Data

Timothy Kanter

Internal Medicine · Bronx, NYNPI 1083706535

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $556,845 of the $630,270 with a category attached, or 88.4%. Viiv Healthcare Company accounts for 64.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $246,508 and has fallen 100.0% since, to $84 in 2023. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$630,270in general payments, 2019–2025

Across 703 payments — averaging $896.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$409K
  • Gilead$94K
  • Merck$69K
  • Janssen Products, LP$52K
  • Theratechnologies Inc.$3K
  • Johnson & Johnson$1K
  • plus $2K from 6 others

What the payments were for

  • Consulting fees$7,2401%
  • Speaking & faculty fees$556,84588%
  • Travel & lodging$47,3928%
  • Food & beverage$18,7933%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$630,270 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Other internal medicine in Bronx

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →